Inducing patent infringement in Hatch-Waxman ANDA litigation

被引:0
|
作者
Main, Denise
机构
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
18-CHAL
引用
收藏
页数:1
相关论文
共 50 条
  • [41] EARNING EXCLUSIVITY: GENERIC DRUG INCENTIVES AND THE HATCH-WAXMAN ACT
    Hemphill, C. Scott
    Lemley, Mark A.
    ANTITRUST LAW JOURNAL, 2011, 77 (03) : 947 - 989
  • [42] CHAL 8 - Why Hatch-Waxman is not a model for biosimilars legislation
    Watt, Stuart
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 950 - 950
  • [43] Interactions between Inter Partes Review and Hatch-Waxman Litigations
    Chen, Feng-Chi
    Lee, Pin-Shen
    Huang, Yun-Yu
    Wu, Huang-Chi
    Lin, Hsuan-Yu
    2019 16TH IEEE INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY - CIBCB 2019, 2019, : 352 - 355
  • [44] Generic Drug Approvals Since the 1984 Hatch-Waxman Act
    Gupta, Ravi
    Kesselheim, Aaron S.
    Downing, Nicholas
    Greene, Jeremy
    Ross, Joseph S.
    JAMA INTERNAL MEDICINE, 2016, 176 (09) : 1391 - 1393
  • [45] The Hatch-Waxman Act: Balancing competing interests or survival of the fittest?
    Behrendt, KE
    FOOD AND DRUG LAW JOURNAL, 2002, 57 (02) : 247 - 271
  • [46] The Hatch-Waxman Act: Encouraging Innovation and Generic Drug Competition
    Sokal, Allen M.
    Gerstenblith, Bart A.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (18) : 1950 - 1959
  • [47] Is Noerr-Pennington immunity still a viable defense against antitrust claims arising from Hatch-Waxman litigation?
    Steinhauer, Esther H.
    FOOD AND DRUG LAW JOURNAL, 2006, 61 (04) : 679 - 700
  • [48] Patent infringement, litigation, and settlement
    Jeon, Haejun
    ECONOMIC MODELLING, 2015, 51 : 99 - 111
  • [49] CONTRIBUTORY INFRINGEMENT IN PATENT LITIGATION
    不详
    YALE LAW JOURNAL, 1931, 40 (08): : 1328 - 1331
  • [50] The Hatch-Waxman Act and the declaratory judgment action: Constitutional and practical implications
    Gu, HH
    RUTGERS LAW REVIEW, 2005, 57 (02) : 771 - 802